InSight shareholder offers to buy firm

Article

A shareholder group that owns one-third of InSight Health Services has offered to buy the rest of the company, the Newport Beach, CA, imaging services firm reported this month. InSight has formed a special committee to evaluate the proposal, which

A shareholder group that owns one-third of InSight Health Services has offered to buy the rest of the company, the Newport Beach, CA, imaging services firm reported this month. InSight has formed a special committee to evaluate the proposal, which InSight executives said was unsolicited.

The proposal was made by investment firms the Carlyle Group and the Halifax Group, which together own 33% of the company. The investor group intends to buy the rest of InSight for $10 a share and merge it with an affiliated company, InSight management said. In addition to forming the special committee, InSight has retained an investment banking firm to consider the bid.

In other InSight news, the company reported financial results for its third quarter (end-March). InSight reported revenues of $40.8 million, up 44% compared with $28.4 million in the same period last year. Much of the increase was due to acquisitions InSight made last year, such as its purchase of Signal Medical Systems (SCAN 4/1/98).

On the profit side, InSight reported net income of $525,000, compared with $1.9 million in the third quarter of 1998. The drop was due to an increase in interest expense of $2.2 million, the company said.

Recent Videos
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.